- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Mankind Pharma Limited — Updates, 30-07-2026: General Updates
30-07-2026 | 04:01 pm
30-07-2026 | 04:01 pm
Mankind Pharma reported robust Q1 results: Consolidated revenue ₹4,030.59 Cr, PAT ₹574.09 Cr. Key moves include a ₹150 Cr corporate guarantee for BSV, divesting Broadway Hospitality for ₹49 Cr, and redeeming ₹1,250 Cr in NCDs. A new Netherlands WOS for R&D was also approved.
No comments yet. Be the first to comment!